PALI PALISADE BIO, INC.: institutional ownership and insider trading
127 funds reported holding $386M of PALISADE BIO, INC. in their latest 13F filings; in Q2 2026 funds net bought $49.9M, with 49 new positions and 21 funds selling out; over the last 12 months insiders bought $297K and sold $421K on the open market.
Famous investors holding PALI
- Renaissance Technologies (Renaissance Technologies): $2.35M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $2.13M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $1.95M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $265K, 0.0% of the portfolio
Largest institutional holders of PALI
- Soleus Capital Management, L.P. — $27.3M
- B Group, Inc. — $23.9M
- AMERIPRISE FINANCIAL INC (AMP) — $23.2M
- Jupiter Topco LLC — $22.4M
- BlackRock, Inc. (BLK) — $21.8M
- Octagon Capital Advisors LP — $21.5M
- JANUS HENDERSON GROUP PLC (JHG) — $18.8M
- PERCEPTIVE ADVISORS LLC — $17.6M
- RA CAPITAL MANAGEMENT, L.P. — $14.9M
- FRANKLIN RESOURCES INC (BEN) — $12.1M
Recent PALI insider trades
- Oct 2, 2026: Williams Donald Allen bought 20,000 shares ($28.8K)
- Jul 9, 2026: Baltera Robert Jr. bought 45,000 shares ($88.8K)
- Jul 7, 2026: Finley John David sold 146,798 shares ($304K)
- Jul 7, 2026: Jones Mitchell Lawrence sold 51,880 shares ($106K)
5%+ owners
- RA Capital Management, L.P.: 9.9% (Schedule 13G/A, filed May 15, 2026)
- Perceptive Advisors LLC: 7.9% (Schedule 13G/A, filed May 15, 2026)
- Soleus Capital Master Fund, L.P.: 7.5% (Schedule 13G/A, filed Aug 13, 2026)
- BlackRock, Inc.: 6.0% (Schedule 13G, filed Jul 29, 2026)
- Ameriprise Financial, Inc.: 5.3% (Schedule 13G, filed May 15, 2026)